Clinical Trials Browser

Prostatic Neoplasms × PROSTVAC × 90 days × Clear all

NCT02649855 2026-04-29

Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer

Phase 2 Completed

74 enrolled 15 charts

Prostatic Neoplasms